STOCK TITAN

Uranium Royalty Corp. (UROY) Financials

UROY
FY2026 annual
Revenue $186.8M +1566.0% YoY
Net Income $40.2M +992.6% YoY
EPS (Diluted) $0.29 +825.0% YoY
Operating Cash Flow $178.5M +1285.0% YoY
Market Cap $1.3B as of Oct 19, 2026
Price / Sales 7.1x on $186.8M revenue, FY2026
Price / Earnings 33.1x on $40.2M net income, FY2026
Price / Book 1.4x on $961.5M equity, Q1 FY2027

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 19, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q1 FY2027, ended Jul 31, 2026 Reported Currency USD FYE April

Newest figures come from the 10-Q for Q1 FY2027, filed Sep 14, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the UROY SEC filings page.

Uranium Royalty Corp. (UROY) reported $186.8M in revenue for fiscal year 2026, up 1566.0% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI UROY FY2026

The business shifted from inventory accumulation and losses to a low-debt model with unusually strong cash conversion.

Cash conversion in FY2026 was unusually high: operating cash flow reached $178.5M against net income of $40.2M while inventory fell from $157.6M to $34.3M. That combination indicates reported cash generation was helped substantially by converting previously accumulated inventory into sales, not just by current-period profitability.

The FY2025 loss gave way to FY2026 operating profit of $48.3M, with operating margin recovering from -30.7% to 25.9%. The rebound reflects a sharp change in business activity and cost absorption rather than a steady, linear improvement.

The balance sheet is lightly debt-funded: FY2026 liabilities were $60.6M against equity of $312.8M, with no reported long-term debt and a 5.9x current ratio. Shares outstanding also rose from 133.6M to 381.1M, showing that expansion was accompanied by substantial equity issuance rather than borrowing.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 62 / 100
Financial Health Score 62/100
Scored as: Energy peer group

Scored against energy companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Uranium Royalty Corp.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
29

Uranium Royalty Corp. has an operating margin of 25.9%, meaning the company retains $26 of operating profit per $100 of revenue. This below-average margin results in a low score of 29/100, suggesting thin profitability after operating expenses. This is up from -30.7% the prior year.

Growth
97

Uranium Royalty Corp.'s revenue surged 1566.0% year-over-year to $186.8M, reflecting rapid business expansion. This strong growth earns a score of 97/100.

Leverage
100

Uranium Royalty Corp. carries a low D/E ratio of 0.00, meaning only $0.00 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
94

With a current ratio of 5.94, Uranium Royalty Corp. holds $5.94 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 94/100.

Cash Flow
0

Not available for Uranium Royalty Corp., and counted as zero in the overall score.

Returns
50

Uranium Royalty Corp.'s ROE of 12.9% shows moderate profitability relative to equity, earning a score of 50/100. This is up from -2.1% the prior year.

Altman Z-Score Safe
15.22

Uranium Royalty Corp. scores 15.22, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($1.3B) relative to total liabilities ($60.5M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
6/8

Uranium Royalty Corp. passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality Cash-Backed
4.43x

For every $1 of reported earnings, Uranium Royalty Corp. generates $4.43 in operating cash flow ($178.5M OCF vs $40.2M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$51.0M
YoY+110.2%

Uranium Royalty Corp. generated $51.0M in revenue in Q1 2027. This represents an increase of 110.2% from the same quarter a year earlier.

EBITDA
$16.6M
YoY+628.4%

Uranium Royalty Corp.'s EBITDA was $16.6M in Q1 2027, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 628.4% from the same quarter a year earlier.

Net Income
$16.2M
YoY+1485.1%

Uranium Royalty Corp. reported $16.2M in net income in Q1 2027. This represents an increase of 1485.1% from the same quarter a year earlier.

EPS (Diluted)
$0.10

Uranium Royalty Corp. earned $0.10 per diluted share (EPS) in Q1 2027.

Cash & Balance Sheet

Cash & Debt
$54.1M
YoY+724.9%
QoQ-77.6%

Uranium Royalty Corp. held $54.1M in cash against $535.7M in long-term debt as of Q1 2027.

Shares Outstanding
381M
QoQ0.0%

Uranium Royalty Corp. had 381M shares outstanding in Q1 2027. It is unchanged from the prior quarter.

Free Cash Flow

Not reported for Q1 2027.

Dividends Per Share

Not reported for Q1 2027.

Margins & Returns

Gross Margin
33.1%
YoY+17.2pp

Uranium Royalty Corp.'s gross margin was 33.1% in Q1 2027, indicating the percentage of revenue retained after direct costs. This is up 17.2 percentage points from the same quarter a year earlier.

Operating Margin
32.2%
YoY+22.9pp

Uranium Royalty Corp.'s operating margin was 32.2% in Q1 2027, reflecting core business profitability. This is up 22.9 percentage points from the same quarter a year earlier.

Net Margin
31.9%
YoY+27.6pp

Uranium Royalty Corp.'s net profit margin was 31.9% in Q1 2027, showing the share of revenue converted to profit. This is up 27.6 percentage points from the same quarter a year earlier.

Return on Equity
1.7%
YoY+1.2pp

Uranium Royalty Corp.'s ROE was 1.7% in Q1 2027, measuring profit generated per dollar of shareholder equity. This is up 1.2 percentage points from the same quarter a year earlier.

Capital Allocation

None of these metrics is reported for Q1 2027.

UROY Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

UROY quarterly income statement
MetricQ1'2710-QQ4'2610-QQ1'2610-QQ4'2510-K
Revenue$51.0M+110.2%N/A$24.2MN/A
Cost of Revenue$34.1M+67.3%N/A$20.4MN/A
Gross Profit$16.9M+336.0%N/A$3.9MN/A
SG&A Expenses$964K-27.6%N/A$1.3MN/A
Operating Income$16.4M+630.1%N/A$2.2MN/A
EBITDA$16.6M+628.4%N/A$2.3MN/A
Interest Expense$499KN/A$0N/A
Income Tax$6.8M+1703.2%N/A$379KN/A
Net Income$16.2M+1485.1%N/A$1.0MN/A
EPS (Basic)$0.10+900.0%N/A$0.01N/A
EPS (Diluted)$0.10N/A$0.01N/A
Diluted Shares (Avg)157MN/A134MN/A

Not reported in any period shown, so not listed: R&D Expenses.

UROY Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

UROY quarterly balance sheet
MetricQ1'2710-QQ4'2610-QQ1'2610-QQ4'2510-K
Total Assets$1.9B$373.3M+72.7%N/A$216.1M
Current Assets$120.8M$329.3M+90.8%N/A$172.6M
Cash & Equivalents$54.1M+724.9%$242.0M+2481.1%$6.6M$9.4M
Short-Term Investments$0$0$0$0
Inventory$220K$34.3M-78.2%N/A$157.6M
Accounts Receivable$4.2M$59K+90.3%N/A$31K
Long-Term Investments$0$0$0$0
Total Liabilities$819.5M$60.5M+5859.6%N/A$1.0M
Current Liabilities$138.0M$55.5M+7406.9%N/A$739K
Non-Current Liabilities$681.5M$5.1M+1731.8%N/A$277K
Long-Term Debt$535.7M$0N/AN/A
Total Equity$961.5M+346.5%$312.8M+45.4%$215.4M$215.1M
Retained Earnings$68.7M$52.5M+329.8%N/A$12.2M

Not reported in any period shown, so not listed: Goodwill.

UROY Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

UROY quarterly cash flow statement
MetricQ1'2710-QQ4'2610-QQ1'2610-QQ4'2510-K
Operating Cash Flow$53.0M+126.2%N/A$23.4MN/A
Depreciation & Amortization$188K+506.5%N/A$31KN/A
Stock-Based Compensation$78K+25.8%N/A$62KN/A
Investing Cash Flow-$265.5M-930.7%N/A-$25.8MN/A
Financing Cash Flow$40.3M+1006300.0%N/A$4KN/A

Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.

UROY Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

UROY quarterly financial ratios
MetricQ1'2710-QQ4'2610-QQ1'2610-QQ4'2510-K
Gross Margin33.1%+17.2ppN/A16.0%N/A
Operating Margin32.2%+22.9ppN/A9.3%N/A
Net Margin31.9%+27.6ppN/A4.2%N/A
Return on Equity1.7%+1.2ppN/A0.5%N/A
Return on Assets0.9%N/AN/AN/A
Current Ratio0.885.94-227.6xN/A233.55
Debt-to-Equity0.560.000.0xN/A0.00
Asset Turnover0.03N/AN/AN/A

Not reported in any period shown, so not listed: FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Uranium Royalty Corp. UROY FY2026 $186.8M $40.2M 21.6% $1.3B 62/100
enCore Energy Corp. EU FY2025 $43.2M -$56.9M N/A $160.6M 51/100
Ur-Energy Inc. URG FY2025 $27.2M -$74.9M N/A $336.7M 40/100
Uranium Energy Corp. UEC FY2026 $37.3M -$137.3M N/A $3.9B 52/100
Energy Fuels Inc. UUUU FY2025 $65.9M -$86K -0.1% $2.2B 47/100
Denison Mines Corp DNN FY2017 $11.1M -$14.2M N/A $2.1B —

Frequently Asked Questions

What is Uranium Royalty Corp.'s annual revenue?

Uranium Royalty Corp. (UROY) reported $186.8M in total revenue for fiscal year 2026. This represents a 1566.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Uranium Royalty Corp.'s revenue growing?

Uranium Royalty Corp. (UROY) revenue grew by 1566.0% year-over-year, from $11.2M to $186.8M in fiscal year 2026.

Is Uranium Royalty Corp. profitable?

Yes, Uranium Royalty Corp. (UROY) reported a net income of $40.2M in fiscal year 2026, with a net profit margin of 21.6%.

Uranium Royalty Corp. (UROY) reported diluted earnings per share of $0.29 for fiscal year 2026. This represents a 825.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Uranium Royalty Corp. (UROY) had EBITDA of $48.4M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2026, Uranium Royalty Corp. (UROY) had $242.0M in cash and equivalents against $0 in long-term debt.

Uranium Royalty Corp. (UROY) had a gross margin of 30.6% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

Uranium Royalty Corp. (UROY) had an operating margin of 25.9% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.

Uranium Royalty Corp. (UROY) had a net profit margin of 21.6% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

Uranium Royalty Corp. (UROY) has a return on equity of 12.9% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

Uranium Royalty Corp. (UROY) generated $178.5M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

Uranium Royalty Corp. (UROY) had $373.3M in total assets as of fiscal year 2026, including both current and long-term assets.

Uranium Royalty Corp. (UROY) had 381M shares outstanding as of fiscal year 2026.

Uranium Royalty Corp. (UROY) had a current ratio of 5.94 as of fiscal year 2026, which is generally considered healthy.

Uranium Royalty Corp. (UROY) had a debt-to-equity ratio of 0.00 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

Uranium Royalty Corp. (UROY) had a return on assets of 10.8% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

Uranium Royalty Corp. (UROY) trades at 33.1x earnings, its market capitalization divided by net income of $40.2M net income, FY2026. The market capitalization is $1.3B as of Oct 19, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Uranium Royalty Corp. (UROY) trades at 7.1x sales, its market capitalization divided by revenue of $186.8M revenue, FY2026. The market capitalization is $1.3B as of Oct 19, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Uranium Royalty Corp. (UROY) has an Altman Z-Score of 15.22, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Uranium Royalty Corp. (UROY) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Uranium Royalty Corp. (UROY) has an earnings quality ratio of 4.43x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Uranium Royalty Corp. (UROY) scores 62 out of 100 on our Financial Health Score, indicating moderate standing within its energy companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top